{
  "disease_name": "Progressive myoclonic epilepsy type 3",
  "orpha_code": "263516",
  "drugs": [
    {
      "name": "Brivaracetam",
      "substance_url": "/en/drug/substance/94738?name=263516&mode=orpha&region=&status=all",
      "substance_id": "94738",
      "regulatory_url": "/en/drug/regulatory/133994?name=263516&mode=orpha&region=",
      "regulatory_id": "133994",
      "orpha_substance_code": "ORPHA:98261",
      "details": [
        "Brivaracetam(Medicinal product                        - 26/08/2005)Disease(s) concernedORPHA:98261 Progressive myoclonic epilepsy",
        "Brivaracetam(Medicinal product                        - 26/08/2005)",
        "(Medicinal product                        - 26/08/2005)",
        "Disease(s) concernedORPHA:98261 Progressive myoclonic epilepsy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/94738?name=263516&mode=orpha&region=&status=all",
          "text": "Brivaracetam",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/98261",
          "text": "ORPHA:98261 Progressive myoclonic epilepsy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133994?name=263516&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "LIBERVANT",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/673903?name=263516&mode=orpha&region=",
      "regulatory_id": "673903",
      "orpha_substance_code": "ORPHA:166463",
      "details": [
        "LIBERVANT(Tradename                        - 26/04/2024)Disease(s) concernedORPHA:166463 Epilepsy syndrome",
        "LIBERVANT(Tradename                        - 26/04/2024)",
        "(Tradename                        - 26/04/2024)",
        "Disease(s) concernedORPHA:166463 Epilepsy syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/673890?name=263516&mode=orpha&region=&status=all",
          "text": "LIBERVANT",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/166463",
          "text": "ORPHA:166463 Epilepsy syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/673903?name=263516&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:59:45.000583",
  "run_number": 2,
  "total_drugs_found": 2,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Progressive+myoclonic+epilepsy+type+3&orphaCode=263516&name=263516&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Progressive myoclonic epilepsy type 3",
    "orphaCode": "263516",
    "name": "263516",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}